lerotinib
Sponsor Sunshine Biopharma INC. · listed as SBFM
READOUT
Phase 3
Confidence: medium
Source: clinicaltrials
Next catalyst
Event typeREADOUT
Expected date2026-08-31
As disclosedAug 2026
Date precisionmonth
Confidencemedium
Trial & sponsor
Trial (NCT)NCT04415853
PhasePHASE3
StatusRECRUITING
Lead sponsorSunshine Lake Pharma Co., Ltd.
Listed asSBFM
Condition(s)Esophageal Cancer
!
Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.
This is one row of the free CSA sample. The full snapshot carries 2,103 forward catalysts across 139 listed sponsors.
Get the full dataset — $499 → More SBFM catalysts